Search by Drug Name or NDC

    NDC 50458-0290-01 SPORANOX 100 mg/1 Details

    SPORANOX 100 mg/1

    SPORANOX is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is ITRACONAZOLE.

    Product Information

    NDC 50458-0290
    Product ID 50458-290_091c35a0-b034-20e9-e063-6294a90a99f5
    Associated GPIs 11407035000120
    GCN Sequence Number 016949
    GCN Sequence Number Description itraconazole CAPSULE 100 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 49101
    HICL Sequence Number 006503
    HICL Sequence Number Description ITRACONAZOLE
    Brand/Generic Brand
    Proprietary Name SPORANOX
    Proprietary Name Suffix n/a
    Non-Proprietary Name ITRACONAZOLE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name ITRACONAZOLE
    Labeler Name Janssen Pharmaceuticals, Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020083
    Listing Certified Through 2024-12-31

    Package

    NDC 50458-0290-01 (50458029001)

    NDC Package Code 50458-290-01
    Billing NDC 50458029001
    Package 3 BLISTER PACK in 1 CARTON (50458-290-01) / 10 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 1992-09-11
    NDC Exclude Flag N
    Pricing Information N/A